Tech & Science
The research was published Oct. 14 in the journal Science Translational Medicine. The paper is titled Loss of GPR3 reduces the amyloid plaque burden...
Hi, what are you looking for?
The research was published Oct. 14 in the journal Science Translational Medicine. The paper is titled Loss of GPR3 reduces the amyloid plaque burden...
The study, using a blood product (where specific blood plasma proteins are extracted and formulated), showed the drug product can reduce brain atrophy and...
Drug to treat agitation Nuedexta is a combination of the cough suppressant dextromethorphan and quinidine, a heart medication. An American research team from a...
Cancer and heart disease deaths have fallen over the past two decades, but deaths from cognitive diseases such as Alzheimer’s disease have risen sharply...
A new study from Public Health England has found that the proportion of people with dementia who are admitted to hospital in an emergency...
The conference ran from July 18-23 and among the final presentations was the study on the results of Alzheimer’s patients taking up a regular...
Phase three drug trials The pharmaceutical company Eli Lily is set to announce the results of its most recent trials of Solanezumab at the...
It’s difficult to imagine our heroes growing older and becoming less competent. They often seem as if they would remain ageless and infallible forever....
Early signs of Alzheimer’s The study comes out of the Rush University Medical Center in Chicago and was published in the American Academy of...
New Alzheimer’s drug trial Being developed by an American pharmaceutical company called Biogen, in a initial trial of 166 people researchers say the drug...